Hyperuricemia remission after colorectal cancer surgery for colorectal cancer patients

Fei Liu,Yin Huang,Zi-Wei Li,Xu-Rui Liu,Xiao-Yu Liu,Quan Lv,Xin-Peng Shu,Lian-Shuo Li,Wei Zhang,Yue Tong,Meng-Hua Zeng,Dong Peng
DOI: https://doi.org/10.1038/s41598-023-46348-w
IF: 4.6
2023-11-03
Scientific Reports
Abstract:The purpose of this study was to investigate whether patients with colorectal cancer (CRC) combined with hyperuricemia remitted 1 year after CRC surgery. CRC patients combined with hyperuricemia who underwent radical surgery were included from a single clinical center from Jan 2016 to Dec 2021. Baseline characteristics was compared between the remission group and the non-remission group. Multivariate logistic regression was used to find the possible predictive factors of hyperuricemia remission. A total of 91 patients were included for data analysis, retrospectively. There were 34 (37.4%) patients in the remission group and 57 (62.6%) patients in the non-remission group. The mean preoperative weight and body mass index (BMI) were 61.2 ± 10.7 (kg) and 24.1 ± 3.3 (kg/m 2 ). 21 (23.1%) patients had a history of drinking. We found that the weight and BMI were not significantly different before and 1 year after CRC surgery ( P > 0.05). In contrast, uric acid values were significantly decreased ( P < 0.01). Meanwhile, the outcomes showed there were no significant differences in the baseline characteristics between the remission and non-remission groups ( P > 0.05). According to multivariate logistic regression, we found that the history of drinking was a predictive factor of hyperuricemia remission (OR = 0.046, 95% CI 0.005–0.475, P = 0.010). CRC patients with hyperuricemia had a 37.4% remission from hyperuricemia 1 year after CRC surgery. Tumor location, tumor stage, and tumor size did not predict the remission of hyperuricemia. Notably, the history of drinking was a predictive factor of hyperuricemia remission.
multidisciplinary sciences
What problem does this paper attempt to address?